Year |
Citation |
Score |
2016 |
Sun J, Fu X, Wang Y, Liu Y, Zhang Y, Hao T, Hu X. Erianin inhibits the proliferation of T47D cells by inhibiting cell cycles, inducing apoptosis and suppressing migration. American Journal of Translational Research. 8: 3077-86. PMID 27508028 |
0.314 |
|
2014 |
Xue M, Yao S, Hu M, Li W, Hao T, Zhou F, Zhu X, Lu H, Qin D, Yan Q, Zhu J, Gao SJ, Lu C. HIV-1 Nef and KSHV oncogene K1 synergistically promote angiogenesis by inducing cellular miR-718 to regulate the PTEN/AKT/mTOR signaling pathway. Nucleic Acids Research. 42: 9862-79. PMID 25104021 DOI: 10.1093/nar/gku583 |
0.303 |
|
2014 |
Zhu X, Guo Y, Yao S, Yan Q, Xue M, Hao T, Zhou F, Zhu J, Qin D, Lu C. Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway. Oncogene. 33: 1986-96. PMID 23604117 DOI: 10.1038/onc.2013.136 |
0.445 |
|
2013 |
Hao T, Rockwell P. Signaling through the vascular endothelial growth factor receptor VEGFR-2 protects hippocampal neurons from mitochondrial dysfunction and oxidative stress. Free Radical Biology & Medicine. 63: 421-31. PMID 23732519 DOI: 10.1016/J.Freeradbiomed.2013.05.036 |
0.698 |
|
2013 |
Zhou F, Xue M, Qin D, Zhu X, Wang C, Zhu J, Hao T, Cheng L, Chen X, Bai Z, Feng N, Gao SJ, Lu C. HIV-1 Tat promotes Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6-induced angiogenesis and tumorigenesis by regulating PI3K/PTEN/AKT/GSK-3β signaling pathway. Plos One. 8: e53145. PMID 23301033 DOI: 10.1371/journal.pone.0053145 |
0.468 |
|
2011 |
Edelstein J, Hao T, Cao Q, Morales L, Rockwell P. Crosstalk between VEGFR2 and muscarinic receptors regulates the mTOR pathway in serum starved SK-N-SH human neuroblastoma cells. Cellular Signalling. 23: 239-48. PMID 20851763 DOI: 10.1016/J.Cellsig.2010.09.008 |
0.448 |
|
2007 |
Gomes E, Papa L, Hao T, Rockwell P. The VEGFR2 and PKA pathways converge at MEK/ERK1/2 to promote survival in serum deprived neuronal cells. Molecular and Cellular Biochemistry. 305: 179-90. PMID 17646929 DOI: 10.1007/S11010-007-9542-2 |
0.625 |
|
Show low-probability matches. |